rhulL-2 adjunctive therapy in multidrug resistant tuberculosis: A comparison of two treatment regimens and placebo

This publication has 8 references indexed in Scilit:

• Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons
  The Journal of Infectious Diseases, 1997
• CD56^bright natural killer cell subsets: Characterization of distinct functional responses to interleukin‐2 and the c‐kit ligand
  European Journal of Immunology, 1997
• Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2
  British Journal of Cancer, 1995
• Modulation of the cytokine and acute-phase response to major surgery by recombinant interleukin-2
  British Journal of Surgery, 1995
• In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses
  British Journal of Cancer, 1994
• Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.
  The Journal of Experimental Medicine, 1993
• The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
  The Journal of Experimental Medicine, 1991
• Interleukin 2
  Annual Review of Immunology, 1984